A Computational Investigation of Curcumin Glucoside in α-Synuclein Aggregation: DFT Characterization, Molecular Docking, and Secondary Data Analysis
8 affiliations
- 1Department of Biotechnology, Koneru Lakshmaiah Education Foundation (Deemed to be University), Vaddeswaram 522302, India
- 2Department of Computer Science and Engineering, APJ Abdul Kalam Technological University, Thiruvananthapuram 695016, India
- 3Department of Computer Science and Engineering, Rajagiri School of Engineering & Technology (Autonomous), Kochi 682039, India
- 4PhD Program in Biosciences and Biotechnology, Faculty of Science and Technology, Universidad Tecnológica de Panamá, Panama City 0819-07289, Panama
- 5División de Salud y Enfermedades Humanas, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama
- 6School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland
- 7División de Bioprospección y Descubrimiento de Fármacos, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama
- 8Sistema Nacional de Investigación (SNI), Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT), Panama City 0816-02852, Panama
Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the aggregation of α-synuclein into oligomers and amyloid fibrils. Curcumin glucoside has been investigated as a potential inhibitor of α-synuclein aggregation; however, understanding its electronic properties and predicted interactions with α-synuclein fibrils may provide additional insights into its potential molecular behavior. This study integrates density functional theory (DFT) calculations, molecular docking, and quantitative analysis of previously published Thioflavin-T (ThT) fluorescence data to investigate the physicochemical properties and potential anti-aggregation effects of curcumin glucoside. DFT calculations were performed on isolated curcumin and curcumin monoglucoside molecules using the B3LYP-D3(BJ)/def2-SVP level of theory with implicit aqueous solvation. The HOMO–LUMO energy gaps were 3.626 eV for curcumin and 3.372 eV for curcumin monoglucoside, while their dipole moments were 7.53 D and 11.19 D, respectively. These differences indicate changes in the electronic structure and molecular polarity associated with glucosylation. Molecular docking against selected α-synuclein fibril structures representing different disease stages showed docking scores ranging from −5.1 to −6.7 kcal/mol for curcumin and from −6.2 to −6.6 kcal/mol for curcumin glucoside. Previously published ThT fluorescence data related to curcumin glucoside were analyzed using a four-parameter logistic (4PL) model to characterize the reported aggregation-response profiles over time. The combined findings provide complementary electronic-structure, docking, and aggregation-kinetic perspectives on curcumin glucoside. Importantly, the DFT calculations were restricted to isolated molecules and did not evaluate electron redistribution, charge-transfer pathways, or reaction energetics within protein–ligand complexes. The docking scores are computational estimates from a scoring function and are not experimentally measured binding affinities. The 4PL analysis is a secondary re-examination of previously published ThT fluorescence data and does not constitute new experimental validation of aggregation inhibition. Collectively, these results supply a computational and quantitative descriptive basis that can guide further experimental and higher-level quantum-chemical investigation of curcumin glucoside as a potential modulator of α-synuclein aggregation; they do not, by themselves, establish a quantum-mechanical mechanism of action.
Related
- Aβ42-Driven α-synuclein Fibril Polymorphism and Distinct Intracellular Aggregation
- Examining the Atypical Structure Adopted by the 37-51 Segment of α-synuclein in the Early Stage of Aggregation
- Peptidomimetics Inspired by α-Synuclein or Its Chaperone αB-Crystallin Differentially Modulate α-Synuclein Aggregation
- State-selective inhibition of alpha-synuclein aggregation by de novo oligomer-binding proteins
- Oxidized EGCG redirects α-synuclein aggregation through shear-selected interactions
BibTeX
@article{emani2026computational,
title = {{A Computational Investigation of Curcumin Glucoside in α-Synuclein Aggregation: DFT Characterization, Molecular Docking, and Secondary Data Analysis}},
author = {Lakshmi Sowmya Emani and Pranathi Jalapally and Gerardo Samudio-Ríos and Jayanth KS Rao and Sminu Izudheen and Johant Lakey-Beitia and K.S Jagannatha Rao},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210158},
url = {https://www.mdpi.com/1422-0067/27/22/10158},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A Computational Investigation of Curcumin Glucoside in α-Synuclein Aggregation: DFT Characterization, Molecular Docking, and Secondary Data Analysis
AU - Lakshmi Sowmya Emani
AU - Pranathi Jalapally
AU - Gerardo Samudio-Ríos
AU - Jayanth KS Rao
AU - Sminu Izudheen
AU - Johant Lakey-Beitia
AU - K.S Jagannatha Rao
PY - 2026
DA - 2026/11/12
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210158
UR - https://www.mdpi.com/1422-0067/27/22/10158
AB - Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the aggregation of α-synuclein into oligomers and amyloid fibrils. Curcumin glucoside has been investigated as a potential inhibitor of α-synuclein aggregation; however, understanding its electronic properties and predicted interactions with α-synuclein fibrils may provide additional insights into its potential molecular behavior. This study integrates density functional theory (DFT) calculations, molecular docking, and quantitative analysis of previously published Thioflavin-T (ThT) fluorescence data to investigate the physicochemical properties and potential anti-aggregation effects of curcumin glucoside. DFT calculations were performed on isolated curcumin and curcumin monoglucoside molecules using the B3LYP-D3(BJ)/def2-SVP level of theory with implicit aqueous solvation. The HOMO–LUMO energy gaps were 3.626 eV for curcumin and 3.372 eV for curcumin monoglucoside, while their dipole moments were 7.53 D and 11.19 D, respectively. These differences indicate changes in the electronic structure and molecular polarity associated with glucosylation. Molecular docking against selected α-synuclein fibril structures representing different disease stages showed docking scores ranging from −5.1 to −6.7 kcal/mol for curcumin and from −6.2 to −6.6 kcal/mol for curcumin glucoside. Previously published ThT fluorescence data related to curcumin glucoside were analyzed using a four-parameter logistic (4PL) model to characterize the reported aggregation-response profiles over time. The combined findings provide complementary electronic-structure, docking, and aggregation-kinetic perspectives on curcumin glucoside. Importantly, the DFT calculations were restricted to isolated molecules and did not evaluate electron redistribution, charge-transfer pathways, or reaction energetics within protein–ligand complexes. The docking scores are computational estimates from a scoring function and are not experimentally measured binding affinities. The 4PL analysis is a secondary re-examination of previously published ThT fluorescence data and does not constitute new experimental validation of aggregation inhibition. Collectively, these results supply a computational and quantitative descriptive basis that can guide further experimental and higher-level quantum-chemical investigation of curcumin glucoside as a potential modulator of α-synuclein aggregation; they do not, by themselves, establish a quantum-mechanical mechanism of action.
SN - 1422-0067
ER -